COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,970 Articles (22,604 medRxiv, 8,366 bioRxiv)

Most recent first Previous |  Page 2312: Articles 23111-23120  | Next

SARS-CoV-2 Quasispecies provides insight into its genetic dynamics during infection
Sun, F., Wang, X., Tan, S., Dan, Y., Lu, Y., Zhang, J., Xu, J., Tan, Z., Xiang, X., Zhou, Y., He, W., Wan, X., Zhang, W., Chen, Y., Tan, W., Deng, G.
10.1101/2020.08.20.258376 — Posted: 2020-08-20
SARS-CoV-2 infection dynamics in lungs of African green monkeys
Speranza, E., Williamson, B. N., Feldmann, F., Sturdevant, G. L., Perez-Perez, L., Mead-White, K., Smith, B. J., Lovaglio, J., Martens, C., Munster, V., Okumura, A., Shaia, C., Feldmann, H., Best, S. M., de Wit, E.
10.1101/2020.08.20.258087 — Posted: 2020-08-20
Development of a high-throughput homogeneous AlphaLISA drug screening assay for the detection of SARS-CoV-2 Nucleocapsid
Gorshkov, K., Chen, C. Z., de la Torre, J. C., Martinez-Sobrido, L. Z., Moran, T., Zheng, W.
10.1101/2020.08.20.258129 — Posted: 2020-08-20
An effective, safe and cost-effective cell-based chimeric vaccine against SARS-CoV2
Cheng, z., Zhang, D., Liu, X., Miao, J., wang, J., Guo, H., Yan, W., Zhang, Z., Lu, S., Zhang, N., Wang, J., Zhang, Z., Liu, W., Zhang, Y., Zhang, L., Dong, J., Lemoine, N. R., Wang, Y.
10.1101/2020.08.19.258244 — Posted: 2020-08-20
A Human-Immune-System mouse model for COVID-19 research(DRAGA mouse: HLA-A2.HLA-DR4.Rag1KO.IL-2Rγc KO.NOD)
Brumeanu, T.-D., Vir, P., Shashikumar, S., Karim, A. F., Kar, S., Chung, K. K., Pratt, K. P., Casares, S. A.
10.1101/2020.08.19.251249 — Posted: 2020-08-20
Mapping the SARS-CoV-2 spike glycoprotein-derived peptidome presented by HLA class II on dendritic cells
Parker, R., Partridge, T., Wormald, C., Kawahara, R., Stalls, V., Aggelakopoulou, M., Parker, J., Powell Doherty, R., Ariosa-Morejon, Y., Lee, E., Saunders, K., Haynes, B. F., Acharya, P., Thaysen-Andersen, M., Borrow, P., Ternette, N.
10.1101/2020.08.19.255901 — Posted: 2020-08-20
Exploring G and C-quadruplex structures as potential targets against the severe acute respiratory syndrome coronavirus 2
Belmonte Reche, E., Serrano-Chacon, I., Gonzalez, C., Gallo, J., Banobre-Lopez, M.
10.1101/2020.08.19.257493 — Posted: 2020-08-20
Air pollution, SARS-CoV-2 transmission, and COVID-19 outcomes: A state-of-the-science review of a rapidly evolving research area
Bhaskar, A., Chandra, J., Braun, D., Cellini, J., Dominici, F.
10.1101/2020.08.16.20175901 — Posted: 2020-08-20
Covid19data.website
malouche, d.
10.1101/2020.08.14.20174995 — Posted: 2020-08-20 Discussion: Onsite
COVID-19: Effectiveness of Non-Pharmaceutical Interventions in the United States before Phased Removal of Social Distancing Protections Varies by Region
Pan, W., Tyrovolas, S., Gine Vazquez, I., Raj, R., Fernandez, D., Zaitchik, B., Lantos, P., Woods, C. W.
10.1101/2020.08.18.20177600 — Posted: 2020-08-20

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).